Deborah H. Telman - Mar 10, 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Amy Kim by Power of Attorney for Deborah H. Telman
Stock symbol
GILD
Transactions as of
Mar 10, 2024
Transactions value $
-$63,552
Form type
4
Date filed
3/12/2024, 04:19 PM
Previous filing
Feb 2, 2024
Next filing
Apr 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +2.56K +21.21% 14.6K Mar 10, 2024 Direct F1, F2
transaction GILD Common Stock Tax liability -$63.6K -846 -5.79% $75.12 13.8K Mar 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2.56K -8.03% 29.3K Mar 10, 2024 Common Stock 2.56K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +55K $0.00 55K Mar 10, 2024 Common Stock 55K $75.12 Direct F4
transaction GILD Restricted Stock Unit Award +10.8K +36.95% 40.1K Mar 10, 2024 Common Stock 10.8K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.